IQV IQV IQVIAホ―ルディングス

 IQVのチャート


 IQVの企業情報

symbol IQV
会社名 IQVIA Holdings Inc (IQV IQVIAホ―ルディングス)
分野(sector)   
産業(industry)   
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 IQVIA・ホルディングス(IQVIA Holdings Inc.)(旧名:Quintiles IMS Holdings Inc.)は統合情報と技術対応の医療サービスを提供する。同社は3つの事業セグメントを運営する。商業ソリューション事業は国家と地方情報、技術ソリューション、ワークフロー分析とコンサルティングサービスを提供する。研究・開発ソリューション事業はバイオ医薬品開発サービスを提供する。同事業はプロジェクト管理、臨床モニタリング、臨床試験サポートサービス、クインタイルズとクエスト(Q2)ソリューション及び戦略的計画・設計等を提供する。統合エンゲージメント・サービス事業は医療供給者エンゲージメントサービス、患者エンゲージメントサービス及び科学戦略、医療業務サービスを提供する。同社の事業は米州、欧州とアフリカ、及びアジア太平洋地域に展開される。  IQVIAホ―ルディングスは米国のライフサイエンス企業。ヘルスケア産業を対象に医療・ヘルスケア情報およびサイエンスによるテクノロジ―ソリュ―ションを提供する。主にバイオ医薬品企業に対し臨床研究および臨床試験サ―ビスを提供するほか、ヘルスケア企業のマ―ケティング・販売戦略支援や、マネジメントコンサルティングを行う。  IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility - enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.
本社所在地 919 998-2000
代表者氏名 Ari Bousbib
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 919-998-2000
設立年月日 1982年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 58000人
url www.quintiles.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 1950.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 28453.43000
売上高 売上高(百万ドル) 10412.00000
企業価値(EV) 企業価値(EV)(百万ドル) 38522.43000
当期純利益 当期純利益(百万ドル) 224.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Iqvia Holdings Inc revenues increased 7% to $10.41B. Net income before extraordinary items decreased 28% to $224M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other segment loss increase of 13% to $1.14B Contract Sales_Medical Solutions segment income decrease of 20% to $59M.

 IQVのテクニカル分析


 IQVのニュース

   PineBridge Investments, L.P. Buys Amgen Inc, IQVIA Holdings Inc, Raymond James Financial Inc, ...  2021/11/09 20:38:25 GuruFocus
Related Stocks: AMGN , IQV , RJF , PG , SBUX , INTU , CERN , SYK , HAS , GL , MRNA , GE , ACN , EWW , CD , CB , MDT , CAG ,
   Kiwi Wealth Investments Limited Partnership Purchases 2,781 Shares of IQVIA Holdings Inc. (NYSE:IQV)  2021/11/05 20:52:47 Dakota Financial News
Kiwi Wealth Investments Limited Partnership raised its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 82,217 shares of the medical research companys stock after purchasing an additional 2,781 shares during the quarter. []
   1832 Asset Management L.P. Has $20.48 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)  2021/11/05 15:46:45 Transcript Daily
1832 Asset Management L.P. boosted its stake in IQVIA Holdings Inc. (NYSE:IQV) by 204,885.4% during the second quarter, Holdings Channel reports. The institutional investor owned 84,044 shares of the medical research companys stock after buying an additional 84,003 shares during the period. 1832 Asset Management L.P.s holdings in IQVIA were worth $20,480,000 as of its []
   IQVIA Holdings Consensus Indicates Potential 11.8% Upside  2021/11/04 12:52:46 DirectorsTalk
IQVIA Holdings found using ticker (IQV) now have 18 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 304 and 250 calculating the mean target price we have 288.22. Now with the previous closing price of 257.83 this indicates there is a potential upside of 11.8%. The 50 day moving average now sits at 250.35 and the 200 moving average now moves to 245.72. The company has a market cap of $48,639m. Visit the company website at: /> [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients'' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
   Great Point Wealth Advisors, LLC Buys WisdomTree U.S. ...  2021/11/03 21:38:26 GuruFocus
Related Stocks: EZM , VRM , PEP , JPST , SGRY , IQV ,
   Harding Loevner Global Equity Fund Q1 2021 Letter  2021/06/02 16:20:00 Seeking Alpha
   Tracking Dan Loeb's Third Point Portfolio - Q1 2021 Update  2021/06/01 12:12:36 Seeking Alpha
   IQVIA Holdings Inc Shares Near 52-Week High - Market Mover  2021/05/11 22:30:00 Kwhen Finance
IQVIA Holdings Inc (IQV) shares closed today at 1.4% below its 52 week high of $237.47, giving the company a market cap of $44B. The stock is currently up 30.6% year-to-date, up 76.8% over the past 12 months, and up 256.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.3%. Trading Activity Trading volume this week was 15.0% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -885.7% The company's stock price performance over the past 12 months beats the peer average by -816.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1735.7% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Earnings Scheduled For April 22, 2021  2021/04/22 08:01:03 Benzinga
Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ: FRBK ) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million. • Travelzoo (NASDAQ: TZOO ) is likely to report quarterly loss at $0.02 per share on revenue of $14.06 million. • Genuine Parts (NYSE: GPC ) is likely to report quarterly earnings at $1.14 per share on revenue of $4.30 billion. • Alaska Air Gr (NYSE: ALK ) is likely to report quarterly loss at $3.63 per share on revenue of $785.58 million. • Banc of California (NYSE: BANC ) is estimated to report quarterly earnings at $0.24 per share on revenue of $62.54 million. • Bryn Mawr Bank (NASDAQ: BMTC ) is estimated to report quarterly earnings at $0.67 per share on revenue of $34.13 million. • D.R. Horton (NYSE: DHI ) is estimated to report quarterly earnings at $2.15 per share on revenue of $6.10 billion. • East West Bancorp (NASDAQ: EWBC ) is projected to report quarterly earnings at $1.24 per share on revenue of $354.11 million.
   Quest Diagnostics Offloads Interest in Q2 Solutions JV To IQVIA  2021/04/01 13:12:25 Benzinga
Quest Diagnostics Inc (NYSE: DGX ) has announced selling the minority share in Q2 Solutions to IQVIA Holdings Inc (NYSE: IQV ) for $760 million in cash. Q2 Solutions provides comprehensive testing, project … Full story available on Benzinga.com
   UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes - Stocks News Feed  2021/02/18 07:00:00 Stocks News Feed
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €1,450,000,000 in aggregate principal amount of senior notes, consisting of €550,000,000 in aggregate principal amount of senior notes due 2026 (the “2026 Notes”) and €900,000,000 in aggregate… Read More »UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes
   IQVIA Holdings Inc. stock rises Wednesday, outperforms market  2021/02/10 21:56:00 MarketWatch
Shares of IQVIA Holdings Inc. advanced 3.39% to $190.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the…
   IQVIA Holdings Inc. (IQV) Q4 2020 Earnings Call Transcript | AlphaStreet  2021/02/10 17:01:03 AlphaStreet
IQVIA Holdings Inc.(NYSE: IQV) Q4 2020 earnings call dated Feb. 10, 2021

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 IQV IQVIAホ―ルディングス IQV )

 twitter  (公式ツイッターやCEOツイッターなど)